25,297 Shares in DENTSPLY SIRONA Inc. $XRAY Purchased by Counterpoint Mutual Funds LLC

Key Points

• Counterpoint Mutual Funds LLC acquired 25,297 shares of DENTSPLY SIRONA Inc., valued at approximately $402,000, marking a significant new investment in the medical instruments supplier.
• DENTSPLY SIRONA reported earnings of $0.52 per share for the last quarter, exceeding analyst estimates, but experienced a 4.9% decline in revenue year-over-year.
• The company has announced a quarterly dividend of $0.16, with an annualized yield of 4.9%, set to be paid on October 10th.

Counterpoint Mutual Funds LLC purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 25,297 shares of the medical instruments supplier's stock, valued at approximately $402,000.

Other large investors also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $25,000. Brooklyn Investment Group acquired a new position in DENTSPLY SIRONA in the first quarter worth approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in DENTSPLY SIRONA in the first quarter worth approximately $26,000. Caitong International Asset Management Co. Ltd increased its holdings in shares of DENTSPLY SIRONA by 8,003.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier's stock valued at $34,000 after buying an additional 2,241 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its position in shares of DENTSPLY SIRONA by 160.2% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 2,805 shares of the medical instruments supplier's stock valued at $45,000 after acquiring an additional 1,727 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Down 2.1%

Shares of NASDAQ:XRAY opened at $12.96 on Wednesday. The company's fifty day moving average is $14.33 and its 200-day moving average is $14.88. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $27.44. The company has a market capitalization of $2.59 billion, a PE ratio of -2.73, a P/E/G ratio of 0.83 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. During the same quarter in the previous year, the company posted $0.49 earnings per share. DENTSPLY SIRONA's quarterly revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 4.9%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's payout ratio is -13.50%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on XRAY shares. Wall Street Zen cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Stifel Nicolaus decreased their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research report on Friday, August 8th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Wells Fargo & Company dropped their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research note on Friday, August 8th. Finally, Barrington Research reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $18.64.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.